Are you Dr. Nellore?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 41 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
908 20th St S
Birmingham, AL 35205Phone+1 205-934-1917Fax+1 617-726-7416
Summary
- Dr. Anoma Nellore, MD is an infectious disease specialist in Birmingham, Alabama. She is currently licensed to practice medicine in Alabama, Maryland, and Massachusetts. She is affiliated with University of Alabama Hospital and is a Research Fellow in Medicine at Massachusetts General Hospital.
Education & Training
- Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2010 - 2012
- University of Pennsylvania Health SystemResidency, Internal Medicine, 2006 - 2009
- Perelman School of Medicine at the University of PennsylvaniaClass of 2006
Certifications & Licensure
- AL State Medical License 2013 - 2024
- MD State Medical License 2013 - 2017
- MA State Medical License 2010 - 2015
- PA State Medical License 2006 - 2010
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Functional Consequences of T-bet Expression in Flu-specific Memory B Cells After Live Attenuated Influenza Vaccine (LAIV) Start of enrollment: 2019 Nov 15
Publications & Presentations
PubMed
- 22 citationsRecommendations on prevention of infections during chimeric antigen receptor T-cell and bispecific antibody therapy in multiple myeloma.Meera Mohan, Rajshekhar Chakraborty, Susan Bal, Anoma Nellore, Muhamed Baljevic
British Journal of Haematology. 2023-12-01 - 106 citationsIFNγ induces epigenetic programming of human T-bethi B cells and promotes TLR7/8 and IL-21 induced differentiation.Esther Zumaquero, Sara L. Stone, Christopher D. Scharer, Scott A. Jenks, Anoma Nellore
Elife. 2019-05-15 - 516 citationsPhase II Trial of Sorafenib in Advanced Thyroid CancerVandana Gupta-Abramson, Andrea B. Troxel, Anoma Nellore, Kanchan Puttaswamy, Maryann Redlinger
Journal of Clinical Oncology. 2008-10-10
Press Mentions
- Who Gets an Organ Transplant? Waitlist Rules Are ComplicatedFebruary 3rd, 2022